Clinical Trial

Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer

Study acronym: PACO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 2, 2025 (before its estimated December 22, 2025 completion). Its status may not reflect the trial's current state.
Summary
Ovarian cancer is the 8th leading cause of cancer-related death in women. Its prognosis is poor, with diagnosis often made at an advanced stage. Patient management has evolved in recent years with more radical surgeries and the introduction of maintenance treatment following neoadjuvant chemotherapy.
Trial Details
NCT Number NCT06907771
Lead Sponsor University Hospital, Strasbourg, France
Conditions Ovarian Cancer
Enrollment 130 participants
Start Date 2024-04-22
Primary Completion 2025-12-22 (estimated)
Study Completion 2025-12-22 (estimated)
Updated on ClinicalTrials.gov 2025-04-02